<DOC>
	<DOC>NCT00257478</DOC>
	<brief_summary>A study for the treatment of hormone refractory prostate cancer (HRPC) in patients previously treated with chemotherapy.</brief_summary>
	<brief_title>A Study for the Treatment of Hormone Refractory Prostate Cancer (HRPC) in Patients Previously Treated With Chemotherapy</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>Histologically or cytologically confirmed prostate cancer. Prior chemotherapy regimen for prostate cancer History of other malignancy in the last 5 years Major surgery within the past 21 days</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>Treatment Efficacy</keyword>
	<keyword>Treatment Effectiveness</keyword>
	<keyword>Disease Management</keyword>
	<keyword>Treatment</keyword>
	<keyword>Safety</keyword>
</DOC>